Russian President Vladimir Putin signed a revised nuclear doctrine on Tuesday stating that any attack on…
-
-
A group of House Republicans is pushing to overhaul how funds are organized at the Federal…
-
President-elect Trump appears to be a politician in a hurry when it comes to staffing his…
-
Olympio Metals Limited (ASX:OLY) (Olympio or the Company) is pleased to announce that it has signed…
-
Red Mountain Mining Limited (“RMX” or the “Company”) is pleased to advise that it has received…
-
Octava Minerals Limited (ASX:OCT) (“Octava” or the “Company”), a Western Australia focused explorer of the new…
-
Description The securities of Sarama Resources Ltd (‘SRR’) will be placed in trading halt at the…
-
Chromium is a metal for the modern age with a bright future. It is one of…
-
John Feneck, portfolio manager and consultant at Feneck Consulting, shared his thoughts on gold’s post-US election…
-
Investing
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology…